Scholar Rock Holding Corp (SRRK)
15.55
+0.44
(+2.95%)
USD |
NASDAQ |
May 03, 12:13
Scholar Rock Total Liabilities (Quarterly): 85.82M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.82M |
| September 30, 2023 | 83.02M |
| June 30, 2023 | 82.40M |
| March 31, 2023 | 86.07M |
| December 31, 2022 | 97.93M |
| September 30, 2022 | 97.04M |
| June 30, 2022 | 94.62M |
| March 31, 2022 | 94.66M |
| December 31, 2021 | 132.37M |
| September 30, 2021 | 111.13M |
| June 30, 2021 | 115.40M |
| March 31, 2021 | 120.05M |
| December 31, 2020 | 127.54M |
| Date | Value |
|---|---|
| September 30, 2020 | 100.44M |
| June 30, 2020 | 74.19M |
| March 31, 2020 | 77.06M |
| December 31, 2019 | 83.48M |
| September 30, 2019 | 66.75M |
| June 30, 2019 | 67.96M |
| March 31, 2019 | 73.46M |
| December 31, 2018 | 74.71M |
| September 30, 2018 | 6.675M |
| June 30, 2018 | 7.366M |
| March 31, 2018 | 6.801M |
| December 31, 2017 | 115.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
66.75M
Minimum
Sep 2019
132.37M
Maximum
Dec 2021
94.63M
Average
94.62M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 7.107B |
| Ocular Therapeutix Inc | 160.93M |
| Alpine Immune Sciences Inc | 51.91M |
| Keros Therapeutics Inc | 37.81M |
| X4 Pharmaceuticals Inc | 96.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 311.04M |
| Shareholders Equity (Quarterly) | 225.22M |